On your experiences of the Community system overall<br>
On any part of the Community system (section 1 of this consultation paper describes the system and those involved directly) <br>
On how you could better contribute to the Community pharmacovigilance system <br>
On suggestions to strengthen the Community pharmacovigilance system. <br>
Any other comments
